ID ACDH4_PARXL Reviewed; 304 AA. AC Q79AF6; Q13FT9; DT 03-NOV-2009, integrated into UniProtKB/Swiss-Prot. DT 05-JUL-2004, sequence version 1. DT 27-MAR-2024, entry version 117. DE RecName: Full=Acetaldehyde dehydrogenase 4; DE EC=1.2.1.10; DE AltName: Full=Acetaldehyde dehydrogenase [acetylating] 4; DE AltName: Full=Propanal dehydrogenase (CoA-propanoylating); DE EC=1.2.1.87; GN Name=bphJ; OrderedLocusNames=Bxeno_C1122; ORFNames=Bxe_C1188; OS Paraburkholderia xenovorans (strain LB400). OC Bacteria; Pseudomonadota; Betaproteobacteria; Burkholderiales; OC Burkholderiaceae; Paraburkholderia. OX NCBI_TaxID=266265; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=8026764; DOI=10.1016/0378-1119(94)90196-1; RA Hofer B., Backhaus S., Timmis K.N.; RT "The biphenyl/polychlorinated biphenyl-degradation locus (bph) of RT Pseudomonas sp. LB400 encodes four additional metabolic enzymes."; RL Gene 144:9-16(1994). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=LB400; RX PubMed=17030797; DOI=10.1073/pnas.0606924103; RA Chain P.S.G., Denef V.J., Konstantinidis K.T., Vergez L.M., Agullo L., RA Reyes V.L., Hauser L., Cordova M., Gomez L., Gonzalez M., Land M., Lao V., RA Larimer F., LiPuma J.J., Mahenthiralingam E., Malfatti S.A., Marx C.J., RA Parnell J.J., Ramette A., Richardson P., Seeger M., Smith D., Spilker T., RA Sul W.J., Tsoi T.V., Ulrich L.E., Zhulin I.B., Tiedje J.M.; RT "Burkholderia xenovorans LB400 harbors a multi-replicon, 9.73-Mbp genome RT shaped for versatility."; RL Proc. Natl. Acad. Sci. U.S.A. 103:15280-15287(2006). RN [3] RP FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, BIOPHYSICOCHEMICAL RP PROPERTIES, SUBUNIT, AND COMPLEX WITH BPHI. RX PubMed=19476337; DOI=10.1021/bi9006644; RA Baker P., Pan D., Carere J., Rossi A., Wang W., Seah S.Y.K.; RT "Characterization of an aldolase-dehydrogenase complex that exhibits RT substrate channeling in the polychlorinated biphenyls degradation RT pathway."; RL Biochemistry 48:6551-6558(2009). RN [4] RP FUNCTION, AND ACTIVITY REGULATION. RX PubMed=20364820; DOI=10.1021/bi100251u; RA Wang W., Baker P., Seah S.Y.; RT "Comparison of two metal-dependent pyruvate aldolases related by convergent RT evolution: substrate specificity, kinetic mechanism, and substrate RT channeling."; RL Biochemistry 49:3774-3782(2010). RN [5] RP MUTAGENESIS OF ILE-195, AND ALDEHYDE CHANNELING MECHANISM. RC STRAIN=LB400; RX PubMed=21838275; DOI=10.1021/bi200960j; RA Carere J., Baker P., Seah S.Y.; RT "Investigating the molecular determinants for substrate channeling in BphI- RT BphJ, an aldolase-dehydrogenase complex from the polychlorinated biphenyls RT degradation pathway."; RL Biochemistry 50:8407-8416(2011). RN [6] RP CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, ACTIVE SITE, REACTION MECHANISM, RP AND MUTAGENESIS OF CYS-131; ASN-170; ILE-171; ILE-195 AND ASP-208. RC STRAIN=LB400; RX PubMed=22574886; DOI=10.1021/bi300407y; RA Baker P., Carere J., Seah S.Y.; RT "Substrate specificity, substrate channeling, and allostery in BphJ: an RT acylating aldehyde dehydrogenase associated with the pyruvate aldolase RT BphI."; RL Biochemistry 51:4558-4567(2012). CC -!- FUNCTION: Catalyzes the conversion of acetaldehyde or propanal to CC acetyl-CoA or propanoyl-CoA, respectively, using NAD(+) and coenzyme A. CC Displays broad specificity since it can utilize aliphatic aldehydes CC from two to five carbons in length as substrates; the aldehyde CC substrates can be directly channeled from the aldolase BphI to the CC dehydrogenase BphJ. Is the final enzyme in the meta-cleavage pathway CC for the degradation of polychlorinated biphenyls (PCBs). Is also able CC to utilize NADP(+) instead of NAD(+). Is not active with succinic CC semialdehyde or picolinaldehyde as substrates. Can also catalyze the CC reverse reaction, i.e. the reductive deacylation of acetyl-CoA to CC acetaldehyde, which is then channeled to the BphI active site. The CC BphI-BphJ enzyme complex exhibits unique bidirectionality in substrate CC channeling and allosteric activation. {ECO:0000269|PubMed:19476337, CC ECO:0000269|PubMed:20364820}. CC -!- CATALYTIC ACTIVITY: CC Reaction=acetaldehyde + CoA + NAD(+) = acetyl-CoA + H(+) + NADH; CC Xref=Rhea:RHEA:23288, ChEBI:CHEBI:15343, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:57540, CC ChEBI:CHEBI:57945; EC=1.2.1.10; CC -!- CATALYTIC ACTIVITY: CC Reaction=CoA + NAD(+) + propanal = H(+) + NADH + propanoyl-CoA; CC Xref=Rhea:RHEA:36027, ChEBI:CHEBI:15378, ChEBI:CHEBI:17153, CC ChEBI:CHEBI:57287, ChEBI:CHEBI:57392, ChEBI:CHEBI:57540, CC ChEBI:CHEBI:57945; EC=1.2.1.87; CC -!- ACTIVITY REGULATION: Bound pyruvate or other intermediates in the aldol CC addition reaction catalyzed by BphI allosterically activates BphJ CC reductive deacylation activity. {ECO:0000269|PubMed:20364820}. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=23.6 mM for acetaldehyde (at pH 8 and 25 degrees Celsius) CC {ECO:0000269|PubMed:19476337}; CC KM=23.1 mM for propanaldehyde (at pH 8 and 25 degrees Celsius) CC {ECO:0000269|PubMed:19476337}; CC KM=31.7 mM for butyraldehyde (at pH 8 and 25 degrees Celsius) CC {ECO:0000269|PubMed:19476337}; CC KM=7.7 mM for isobutyraldehyde (at pH 8 and 25 degrees Celsius) CC {ECO:0000269|PubMed:19476337}; CC KM=34.8 uM for NAD(+) (at pH 8 and 25 degrees Celsius) CC {ECO:0000269|PubMed:19476337}; CC KM=561 uM for NADP(+) (at pH 8 and 25 degrees Celsius) CC {ECO:0000269|PubMed:19476337}; CC Note=kcat is 17.2 and 16.3 sec(-1) with acetaldehyde and CC propanaldehyde as substrate, respectively (at pH 8 and 25 degrees CC Celsius).; CC -!- PATHWAY: Xenobiotic degradation; polychlorinated biphenyl degradation. CC -!- SUBUNIT: Heterotetramer composed of two BphI (aldolase) and two BphJ CC (dehydrogenase). {ECO:0000269|PubMed:19476337}. CC -!- SIMILARITY: Belongs to the acetaldehyde dehydrogenase family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; CP000272; ABE37050.1; -; Genomic_DNA. DR EMBL; X76500; CAA54035.1; -; Genomic_DNA. DR RefSeq; WP_003450975.1; NZ_CP008761.1. DR AlphaFoldDB; Q79AF6; -. DR SMR; Q79AF6; -. DR STRING; 266265.Bxe_C1188; -. DR KEGG; bxb:DR64_8617; -. DR KEGG; bxe:Bxe_C1188; -. DR eggNOG; COG4569; Bacteria. DR OrthoDB; 9786743at2; -. DR BRENDA; 1.2.1.10; 7691. DR BRENDA; 1.2.1.87; 7691. DR SABIO-RK; Q79AF6; -. DR UniPathway; UPA01002; -. DR Proteomes; UP000001817; Chromosome 3. DR GO; GO:0008774; F:acetaldehyde dehydrogenase (acetylating) activity; IEA:UniProtKB-UniRule. DR GO; GO:0051287; F:NAD binding; IEA:UniProtKB-UniRule. DR GO; GO:0019439; P:aromatic compound catabolic process; IEA:UniProtKB-UniRule. DR Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 1. DR HAMAP; MF_01657; Ac_ald_DH_ac; 1. DR InterPro; IPR003361; Acetaldehyde_dehydrogenase. DR InterPro; IPR015426; Acetylaldehyde_DH_C. DR InterPro; IPR036291; NAD(P)-bd_dom_sf. DR InterPro; IPR000534; Semialdehyde_DH_NAD-bd. DR NCBIfam; TIGR03215; ac_ald_DH_ac; 1. DR Pfam; PF09290; AcetDehyd-dimer; 1. DR Pfam; PF01118; Semialdhyde_dh; 1. DR PIRSF; PIRSF015689; Actaldh_dh_actl; 1. DR SMART; SM00859; Semialdhyde_dh; 1. DR SUPFAM; SSF55347; Glyceraldehyde-3-phosphate dehydrogenase-like, C-terminal domain; 1. DR SUPFAM; SSF51735; NAD(P)-binding Rossmann-fold domains; 1. PE 1: Evidence at protein level; KW Allosteric enzyme; Aromatic hydrocarbons catabolism; NAD; NADP; KW Oxidoreductase. FT CHAIN 1..304 FT /note="Acetaldehyde dehydrogenase 4" FT /id="PRO_0000387931" FT ACT_SITE 131 FT /note="Acyl-thioester intermediate" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01657, FT ECO:0000269|PubMed:22574886" FT BINDING 162..170 FT /ligand="NAD(+)" FT /ligand_id="ChEBI:CHEBI:57540" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01657" FT BINDING 273 FT /ligand="NAD(+)" FT /ligand_id="ChEBI:CHEBI:57540" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01657" FT SITE 195 FT /note="Responsible for governing aldehyde substrate chain FT length specificity" FT MUTAGEN 131 FT /note="C->A,S: Loss of catalytic activity. Still able to FT bind NAD(+), however with much lower affinity." FT /evidence="ECO:0000269|PubMed:22574886" FT MUTAGEN 170 FT /note="N->A,D: Displays significant reduction in the level FT of allosteric activation of the aldol cleavage reaction by FT BphI." FT /evidence="ECO:0000269|PubMed:22574886" FT MUTAGEN 171 FT /note="I->A,F: Exhibits preferences for aldehydes similar FT as wild-type. Exhibits about 80% of wild-type acetaldehyde FT channeling efficiency. Displays significant reduction in FT the level of allosteric activation of the aldol cleavage FT reaction by BphI." FT /evidence="ECO:0000269|PubMed:22574886" FT MUTAGEN 195 FT /note="I->A: 5-fold decrease in affinity for acetaldehyde. FT Increase in affinity for butyraldehyde and pentaldehyde, FT leading to a 9- and 20-fold increase in catalytic FT efficiency with butyraldehyde and pentaldehyde as FT substrate, respectively. Exhibits 84% of wild-type FT acetaldehyde channeling efficiency." FT /evidence="ECO:0000269|PubMed:21838275, FT ECO:0000269|PubMed:22574886" FT MUTAGEN 195 FT /note="I->F: 4- to 7-fold decrease in catalytic efficiency FT with aldehydes three to four carbons in length. Does not FT significantly reduce the channeling efficiency of the FT enzyme complex toward acetaldehyde or propanaldehyde." FT /evidence="ECO:0000269|PubMed:21838275, FT ECO:0000269|PubMed:22574886" FT MUTAGEN 195 FT /note="I->L: Does not significantly reduce the channeling FT efficiency of the enzyme complex toward acetaldehyde or FT propanaldehyde." FT /evidence="ECO:0000269|PubMed:21838275, FT ECO:0000269|PubMed:22574886" FT MUTAGEN 195 FT /note="I->W: 5- to 16-fold decrease in catalytic efficiency FT with aldehydes two to four carbons in length. Exhibits 59% FT of wild-type acetaldehyde channeling efficiency." FT /evidence="ECO:0000269|PubMed:21838275, FT ECO:0000269|PubMed:22574886" FT MUTAGEN 208 FT /note="D->A: 2-fold decrease in catalytic efficiency." FT /evidence="ECO:0000269|PubMed:22574886" SQ SEQUENCE 304 AA; 32237 MW; 3E9DDD9192B7D1AF CRC64; MTKKIKCALI GPGNIGTDLL AKLQRSPVLE PIWMVGIDPE SDGLKRAREM GIKTTADGVD GLIPHMQADG VQIVFDATSA YVHADNSRKV NALGALMIDL TPAAIGPFCV PTVNLKEHVG KGEMNVNMVT CGGQATIPMV AAVSRVQPVA YGEIVATVSS KSAGPGTRKN IDEFTRTTAG AVEKVGGAKK GKAIIILNPA EPPLIMRDTV HCLLESEPDQ AKITESIHAM IKEVQKYVPG YKLVNGPVFD GLRVSVYLEV EGLGDYLPKY AGNLDIMTAA AARTAEMFAE EILAGQLTLQ PVHA //